Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6

Determination of the crystal structure of the zebrafish LPA 6 receptor shows that the lipid ligand binds to an unusual ligand-binding pocket in the receptor that is laterally accessible through the membrane. Lipid-signalling receptor accessible from the cell membrane The lysophosphatidic acid (LPA)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2017-08, Vol.548 (7667), p.356-360
Hauptverfasser: Taniguchi, Reiya, Inoue, Asuka, Sayama, Misa, Uwamizu, Akiharu, Yamashita, Keitaro, Hirata, Kunio, Yoshida, Masahito, Tanaka, Yoshiki, Kato, Hideaki E., Nakada-Nakura, Yoshiko, Otani, Yuko, Nishizawa, Tomohiro, Doi, Takayuki, Ohwada, Tomohiko, Ishitani, Ryuichiro, Aoki, Junken, Nureki, Osamu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Determination of the crystal structure of the zebrafish LPA 6 receptor shows that the lipid ligand binds to an unusual ligand-binding pocket in the receptor that is laterally accessible through the membrane. Lipid-signalling receptor accessible from the cell membrane The lysophosphatidic acid (LPA) receptors are a group of G-protein-coupled receptors (GPCRs) implicated in the development of cancer and fibrosis. The six LPA receptors consist of LPA 1 –LPA 3 and the recently discovered LPA 4 –LPA 6 . LPA 4 –LPA 6 are interesting potential therapeutic targets—the LPA 6 gene deletion, for example, results in congenital hair loss—but lack of structural data has hampered research efforts in this area. Here, Osamu Nureki and colleagues report the crystal structure of the zebrafish LPA 6 receptor, which contains an unusual ligand binding pocket that is open to the cell membrane. The authors propose that the lipid ligand binds to this lateral pocket. This work provides information on ligand recognition and could inform potential drug discovery efforts. Lysophosphatidic acid (LPA) is a bioactive lipid composed of a phosphate group, a glycerol backbone, and a single acyl chain that varies in length and saturation. LPA activates six class A G-protein-coupled receptors to provoke various cellular reactions 1 . Because LPA signalling has been implicated in cancer 2 and fibrosis 3 , the LPA receptors are regarded as promising drug targets. The six LPA receptors are subdivided into the endothelial differentiation gene (EDG) family (LPA 1 –LPA 3 ) 1 and the phylogenetically distant non-EDG family (LPA 4 –LPA 6 ) 4 . The structure of LPA 1 has enhanced our understanding of the EDG family of LPA receptors 5 . By contrast, the functional and pharmacological characteristics of the non-EDG family of LPA receptors have remained unknown, owing to the lack of structural information. Although the non-EDG LPA receptors share sequence similarity with the P2Y family of nucleotide receptors 4 , the LPA recognition mechanism cannot be deduced from the P2Y 1 and P2Y 12 structures 6 , 7 , 8 because of the large differences in the chemical structures of their ligands. Here we determine the 3.2 Å crystal structure of LPA 6 , the gene deletion of which is responsible for congenital hair loss 9 , 10 , to clarify the ligand recognition mechanism of the non-EDG family of LPA receptors. Notably, the ligand-binding pocket of LPA 6 is laterally open towards the membrane, and the acyl chain of the
ISSN:0028-0836
1476-4687
DOI:10.1038/nature23448